These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 237115)

  • 21. Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus.
    Ferris RM; Tang FL
    J Pharmacol Exp Ther; 1979 Sep; 210(3):422-8. PubMed ID: 39160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of norepinephrine from organ-cultured superior cervical ganglia: effects of the norepinephrine uptake inhibitor xylamine.
    Fischer JB; Cho AK
    J Pharmacol Exp Ther; 1983 Jun; 225(3):623-9. PubMed ID: 6864523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noradrenaline and dopamine interaction in rat brain during development.
    Ponzio F; Hallman H; Jonsson G
    Med Biol; 1981 Jun; 59(3):161-9. PubMed ID: 6796787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated amphetamine couples norepinephrine transporter and calcium channel activities in PC12 cells.
    Kantor L; Zhang M; Guptaroy B; Park YH; Gnegy ME
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1044-51. PubMed ID: 15340003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noradrenergic subsensitivity and supersensitivity of the cerebral cortex after reserpine treatment.
    Palmer DS; French SW; Narod ME
    J Pharmacol Exp Ther; 1976 Jan; 196(1):167-71. PubMed ID: 173828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acute and chronic amphetamine treatment on Purkinje neuron discharge in rat cerebellum.
    Freedman R; Marwaha J
    J Pharmacol Exp Ther; 1980 Mar; 212(3):390-6. PubMed ID: 7359342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norepinephrine and adenosine triphosphate release in different ratio from guinea pig vas deferens by high potassium chloride, ouabain and monensin.
    Katsuragi T; Tokunaga T; Miyamoto K; Kuratomi L; Furukawa T
    J Pharmacol Exp Ther; 1988 Oct; 247(1):302-8. PubMed ID: 3139867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible mechanisms involved in the hyperthermic effect caused by reserpine after pretreatment with amphetamine or tranylcypromine in conscious rat.
    Cremades A; Jané F; Serrano JS; Milanés MV
    Methods Find Exp Clin Pharmacol; 1982; 4(8):569-73. PubMed ID: 7169844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of drugs on accumulation and release of catecholamines in rat brain slices.
    Howd RA; Horita A
    Arch Int Pharmacodyn Ther; 1975 Dec; 218(2):231-8. PubMed ID: 1212021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic and possible nonadrenergic sources of adenosine 5'-triphosphate release from nerve varicosities isolated from ileal myenteric plexus.
    Al-Humayyd M; White TD
    J Pharmacol Exp Ther; 1985 Jun; 233(3):796-800. PubMed ID: 3925125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of [3H]noradrenaline from perfused rat hearts by potassium and its modifications by 6-hydroxydopamine and reserpine.
    Carpenter JR; Nash CW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):907-15. PubMed ID: 1021224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses.
    Sporn JR; Wolfe BB; Harden TK; Molinoff PB
    Mol Pharmacol; 1977 Nov; 13(6):1170-80. PubMed ID: 201833
    [No Abstract]   [Full Text] [Related]  

  • 35. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.
    Harris JE; Baldessarini RJ
    Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of central action of octopamine.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1979; 31(5):509-16. PubMed ID: 121158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine.
    Häggendal J; Hamberger B
    Acta Physiol Scand; 1967; 70(3):277-80. PubMed ID: 4293470
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA).
    Evans JM; Cohen G
    J Neurochem; 1989 May; 52(5):1461-7. PubMed ID: 2496200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 6-hydroxydopamine on central noradrenaline neurons during ontogeny.
    Sachs C; Jonsson G
    Brain Res; 1975 Dec; 99(2):277-91. PubMed ID: 1182547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.